(NASDAQ: LMAT) Lemaitre Vascular's forecast annual revenue growth rate of 9.38% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.88%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.36%.
Lemaitre Vascular's revenue in 2025 is $226,256,000.On average, 5 Wall Street analysts forecast LMAT's revenue for 2025 to be $5,560,156,167, with the lowest LMAT revenue forecast at $5,540,137,562, and the highest LMAT revenue forecast at $5,600,916,396. On average, 5 Wall Street analysts forecast LMAT's revenue for 2026 to be $6,089,361,314, with the lowest LMAT revenue forecast at $5,917,463,408, and the highest LMAT revenue forecast at $6,272,872,722.
In 2027, LMAT is forecast to generate $6,703,001,591 in revenue, with the lowest revenue forecast at $6,272,194,891 and the highest revenue forecast at $7,025,716,864.